Janux Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16M | 655k | 24.44 |
| 2025-03-31 | $7.7M | 286k | 27.00 |
| 2024-12-31 | $20M | 380k | 53.54 |
| 2024-09-30 | $14M | 316k | 45.43 |
| 2024-06-30 | $14M | 345k | 41.89 |
| 2024-03-31 | $13M | 347k | 37.65 |
| 2023-12-31 | $429k | 40k | 10.73 |
| 2023-09-30 | $147k | 15k | 10.08 |
| 2023-06-30 | $270k | 23k | 11.87 |
| 2022-12-31 | $192k | 15k | 13.17 |
| 2022-06-30 | $194k | 16k | 12.23 |
| 2022-03-31 | $257k | 18k | 14.33 |
| 2021-12-31 | $291k | 15k | 19.73 |